4.37
price down icon1.80%   -0.08
after-market アフターアワーズ: 4.45 0.08 +1.83%
loading

Lipocine Inc (LPCN) 最新ニュース

pulisher
02:10 AM

Lipocine Updates Corporate Presentation, Files 8-K with SEC - Defense World

02:10 AM
pulisher
Jan 17, 2025

StockNews.com Initiates Coverage on Lipocine (NASDAQ:LPCN) - Defense World

Jan 17, 2025
pulisher
Jan 12, 2025

(LPCN) On The My Stocks Page - Stock Traders Daily

Jan 12, 2025
pulisher
Jan 09, 2025

Lipocine (NASDAQ:LPCN) Now Covered by Analysts at StockNews.com - Defense World

Jan 09, 2025
pulisher
Jan 01, 2025

StockNews.com Begins Coverage on Lipocine (NASDAQ:LPCN) - Defense World

Jan 01, 2025
pulisher
Dec 31, 2024

Light Vision 2024 Shenzhen International Optics Fair - GlobeNewswire Inc.

Dec 31, 2024
pulisher
Dec 19, 2024

FDA Grants Fast Track Designation to Lipocine (NASDAQ:LPCN) for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis - Defense World

Dec 19, 2024
pulisher
Dec 17, 2024

Lipocine Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits - Quantisnow

Dec 17, 2024
pulisher
Dec 17, 2024

FDA fast tracks Lipocine's sarcopenia treatment - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis - PR Newswire

Dec 17, 2024
pulisher
Dec 17, 2024

FDA Grants Fast Track Designation to LPCN 1148 as Treatment for Sarcopenia - Contract Pharma

Dec 17, 2024
pulisher
Dec 16, 2024

Lipocine (NASDAQ:LPCN) Now Covered by StockNews.com - Defense World

Dec 16, 2024
pulisher
Dec 11, 2024

Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference - The Eastern Progress Online

Dec 11, 2024
pulisher
Dec 11, 2024

Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session - The Eastern Progress Online

Dec 11, 2024
pulisher
Dec 11, 2024

Where are the Opportunities in (LPCN) - Stock Traders Daily

Dec 11, 2024
pulisher
Dec 06, 2024

Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024 - The Eastern Progress Online

Dec 06, 2024
pulisher
Dec 06, 2024

Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference - The Eastern Progress Online

Dec 06, 2024
pulisher
Nov 29, 2024

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024 - GuruFocus.com

Nov 29, 2024
pulisher
Nov 25, 2024

Lipocine Announces Supply and Distribution Agreement with Pharma - GuruFocus.com

Nov 25, 2024
pulisher
Nov 09, 2024

Lipocine (NASDAQ:LPCN) Announces Financial Results for the Quarter Ended September 30, 2024 - Defense World

Nov 09, 2024
pulisher
Nov 08, 2024

When the Price of (LPCN) Talks, People Listen - Stock Traders Daily

Nov 08, 2024
pulisher
Nov 07, 2024

Lipocine: Q3 Earnings Snapshot - CT Insider

Nov 07, 2024
pulisher
Nov 07, 2024

Lipocine Inc. (LPCN) Quarterly 10-Q Report - Quartz

Nov 07, 2024
pulisher
Nov 07, 2024

Lipocine Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 06, 2024

Lipocine (NASDAQ:LPCN) Presents Positive Data on LPCN 2401 at Obesity Society Conference - Defense World

Nov 06, 2024
pulisher
Oct 31, 2024

Lipocine inks deal to bring TLANDO to South Korea - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Lipocine Partners With SPC Korea For TLANDO In South Korea - Contract Pharma

Oct 31, 2024
pulisher
Oct 31, 2024

Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea - Morningstar

Oct 31, 2024
pulisher
Oct 30, 2024

Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study i - GuruFocus.com

Oct 30, 2024
pulisher
Oct 28, 2024

Trading (LPCN) With Integrated Risk Controls - Stock Traders Daily

Oct 28, 2024
pulisher
Oct 28, 2024

Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1 - GuruFocus.com

Oct 28, 2024
pulisher
Oct 25, 2024

Lipocine Announces Completion of Dosing in Pivotal Study of Post - GuruFocus.com

Oct 25, 2024
pulisher
Oct 18, 2024

(LPCN) Trading Signals - Stock Traders Daily

Oct 18, 2024
pulisher
Oct 16, 2024

Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Bod - GuruFocus.com

Oct 16, 2024
pulisher
Oct 11, 2024

Lipocine reports promising oral brexanolone study results By Investing.com - Investing.com Australia

Oct 11, 2024
pulisher
Oct 11, 2024

Lipocine reports promising oral brexanolone study results - Investing.com India

Oct 11, 2024
pulisher
Oct 10, 2024

Lipocine Enters Exclusive Supply And Distribution Agreement With Pharmalink - Contract Pharma

Oct 10, 2024
pulisher
Oct 10, 2024

Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results - PR Newswire

Oct 10, 2024
pulisher
Oct 09, 2024

Lipocine signs supply and distribution agreement with Pharmalink for Tlando - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Lipocine partners with Pharmalink for GCC distribution of TLANDO - Investing.com

Oct 08, 2024
pulisher
Oct 08, 2024

Lipocine partners with Pharmalink for GCC distribution of TLANDO By Investing.com - Investing.com Nigeria

Oct 08, 2024
pulisher
Oct 08, 2024

Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries - PR Newswire

Oct 08, 2024
pulisher
Sep 24, 2024

Alliance Global Partners Initiates Coverage on Lipocine (NASDAQ:LPCN) - Defense World

Sep 24, 2024
pulisher
Sep 21, 2024

Lipocine (NASDAQ:LPCN) Upgraded to Buy at StockNews.com - Defense World

Sep 21, 2024
pulisher
Sep 18, 2024

‘Lubber Pandhu also has strong emotions beyond cricket’ - DTNEXT

Sep 18, 2024
pulisher
Sep 18, 2024

Louisiana-Pacific director sells $245,750 in company stock By Investing.com - Investing.com Canada

Sep 18, 2024
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
大文字化:     |  ボリューム (24 時間):